Literature DB >> 33288960

Screening for functional circular RNAs using the CRISPR-Cas13 system.

Siqi Li1, Xiang Li1, Wei Xue2, Lin Zhang3, Liang-Zhong Yang1, Shi-Meng Cao1, Yun-Ni Lei2,4, Chu-Xiao Liu1, Si-Kun Guo1, Lin Shan1, Man Wu1, Xiao Tao1, Jia-Lin Zhang1,5, Xiang Gao1,4, Jun Zhang1, Jia Wei2, Jinsong Li6,7,8, Li Yang9,10, Ling-Ling Chen11,12,13.   

Abstract

Circular RNAs (circRNAs) produced from back-spliced exons are widely expressed, but individual circRNA functions remain poorly understood owing to the lack of adequate methods for distinguishing circRNAs from cognate messenger RNAs with overlapping exons. Here, we report that CRISPR-RfxCas13d can effectively discriminate circRNAs from mRNAs by using guide RNAs targeting sequences spanning back-splicing junction (BSJ) sites featured in RNA circles. Using a lentiviral library that targets sequences across BSJ sites of highly expressed human circRNAs, we show that a group of circRNAs are important for cell growth mostly in a cell-type-specific manner and that a common oncogenic circRNA, circFAM120A, promotes cell proliferation by preventing the mRNA for family with sequence similarity 120A (FAM120A) from binding the translation inhibitor IGF2BP2. Further application of RfxCas13d-BSJ-gRNA screening has uncovered circMan1a2, which has regulatory potential in mouse embryo preimplantation development. Together, these results establish CRISPR-RfxCas13d as a useful tool for the discovery and functional study of circRNAs at both individual and large-scale levels.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33288960     DOI: 10.1038/s41592-020-01011-4

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   47.990


  45 in total

Review 1.  CRISPR in cancer biology and therapy.

Authors:  Alyna Katti; Bianca J Diaz; Christina M Caragine; Neville E Sanjana; Lukas E Dow
Journal:  Nat Rev Cancer       Date:  2022-02-22       Impact factor: 60.716

Review 2.  The emerging roles of circRNAs in cancer and oncology.

Authors:  Lasse S Kristensen; Theresa Jakobsen; Henrik Hager; Jørgen Kjems
Journal:  Nat Rev Clin Oncol       Date:  2021-12-15       Impact factor: 66.675

Review 3.  Screening circular RNAs with functional potential using the RfxCas13d/BSJ-gRNA system.

Authors:  Siqi Li; Hao Wu; Ling-Ling Chen
Journal:  Nat Protoc       Date:  2022-07-13       Impact factor: 17.021

4.  High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Authors:  Huawei Tong; Jia Huang; Qingquan Xiao; Bingbing He; Xue Dong; Yuanhua Liu; Xiali Yang; Dingyi Han; Zikang Wang; Xuchen Wang; Wenqin Ying; Runze Zhang; Yu Wei; Chunlong Xu; Yingsi Zhou; Yanfei Li; Minqing Cai; Qifang Wang; Mingxing Xue; Guoling Li; Kailun Fang; Hainan Zhang; Hui Yang
Journal:  Nat Biotechnol       Date:  2022-08-11       Impact factor: 68.164

Review 5.  Best practices to ensure robust investigation of circular RNAs: pitfalls and tips.

Authors:  Samantha Dodbele; Nebibe Mutlu; Jeremy E Wilusz
Journal:  EMBO Rep       Date:  2021-02-25       Impact factor: 8.807

Review 6.  Identifying and characterizing virus-encoded circular RNAs.

Authors:  Takanobu Tagawa; Vishal N Kopardé; Joseph M Ziegelbauer
Journal:  Methods       Date:  2021-03-11       Impact factor: 3.608

Review 7.  Using Drosophila to uncover molecular and physiological functions of circRNAs.

Authors:  Aishwarya Krishnamoorthy; Sebastian Kadener
Journal:  Methods       Date:  2021-04-24       Impact factor: 3.608

Review 8.  Fast and furious: insights of back splicing regulation during nascent RNA synthesis.

Authors:  Wei Xue; Xu-Kai Ma; Li Yang
Journal:  Sci China Life Sci       Date:  2021-02-09       Impact factor: 6.038

Review 9.  Targeting circular RNAs as a therapeutic approach: current strategies and challenges.

Authors:  Alina T He; Jinglei Liu; Feiya Li; Burton B Yang
Journal:  Signal Transduct Target Ther       Date:  2021-05-21

Review 10.  Programmable technologies to manipulate gene expression at the RNA level.

Authors:  Huachun Liu; Simone Rauch; Bryan C Dickinson
Journal:  Curr Opin Chem Biol       Date:  2021-04-27       Impact factor: 8.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.